High Tide reported record third-quarter fiscal 2026 results, with revenue rising 33% year over year and 11% sequentially to CAD 198.8 million for the quarter ended July 31, 2026. Adjusted EBITDA increased 52% from a year earlier and 17% sequentially to CAD 16.2 million, an 8.2% margin that was the company's highest in 12 quarters, while operating income totaled CAD 8.7 million and reported net income reached a record CAD 12.7 million. Chief Executive Officer Raj Grover said the quarter was the strongest financial performance in company history, and Chief Financial Officer Mayank Mahajan noted consolidated gross margin held at 27%, with brick-and-mortar at 27% and medical cannabis distribution at 26%. High Tide generated CAD 7 million in free cash flow, its best in four quarters, and operated 232 Canna Cabana stores in Canada, on track to add 20 during calendar 2026 toward a long-term goal of 350 locations. Its German Remexian medical cannabis distribution business sold 10.2 metric tons, up 35% sequentially, generating CAD 38.2 million in revenue and CAD 4.4 million in adjusted EBITDA, and management said it is evaluating international opportunities including the United Kingdom while prioritizing disciplined deal-making in Canada and Germany.
High Tide IncHigh Tide reported record Q3 revenue of CAD 198.8M, up 33%, with record net income of CAD 12.7M and 52% higher adjusted EBITDA.
High Tide's German Remexian medical cannabis distribution sold 10.2 metric tons, up 35% sequentially, generating CAD 38.2M revenue.
